BR9915897A - Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos. - Google Patents

Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos.

Info

Publication number
BR9915897A
BR9915897A BR9915897-3A BR9915897A BR9915897A BR 9915897 A BR9915897 A BR 9915897A BR 9915897 A BR9915897 A BR 9915897A BR 9915897 A BR9915897 A BR 9915897A
Authority
BR
Brazil
Prior art keywords
transfer
nucleic acid
nucleic acids
human
composition
Prior art date
Application number
BR9915897-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean Herscovici
Hans Hofland
Christophe Jacopin
Daniel Sherman
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9815309A external-priority patent/FR2786700B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR9915897A publication Critical patent/BR9915897A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
BR9915897-3A 1998-12-03 1999-12-02 Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos. BR9915897A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9815309A FR2786700B1 (fr) 1998-12-03 1998-12-03 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
US11718499P 1999-01-26 1999-01-26
PCT/FR1999/002995 WO2000032803A2 (fr) 1998-12-03 1999-12-02 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations

Publications (1)

Publication Number Publication Date
BR9915897A true BR9915897A (pt) 2001-08-21

Family

ID=26234691

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915897-3A BR9915897A (pt) 1998-12-03 1999-12-02 Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos.

Country Status (13)

Country Link
EP (1) EP1137793A2 (cs)
JP (1) JP2002531468A (cs)
KR (1) KR20010101116A (cs)
CN (1) CN1348498A (cs)
AU (1) AU772033B2 (cs)
BR (1) BR9915897A (cs)
CA (1) CA2353576A1 (cs)
CZ (1) CZ20011909A3 (cs)
HU (1) HUP0200345A3 (cs)
IL (1) IL142704A0 (cs)
NO (1) NO20012684L (cs)
PL (1) PL348513A1 (cs)
WO (1) WO2000032803A2 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
JP2005080598A (ja) * 2003-09-10 2005-03-31 Japan Science & Technology Agency β−1,3−グルカン誘導体を用いるプラスミドDNAの導入法
CN103820320B (zh) * 2013-06-25 2017-03-15 宁波有成生物医药科技有限公司 一种非冻型rna保护液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4690596A (en) * 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
AU772033B2 (en) 2004-04-08
WO2000032803A3 (fr) 2000-10-12
PL348513A1 (en) 2002-06-03
EP1137793A2 (fr) 2001-10-04
KR20010101116A (ko) 2001-11-14
IL142704A0 (en) 2002-03-10
JP2002531468A (ja) 2002-09-24
HUP0200345A3 (en) 2003-12-29
HUP0200345A2 (hu) 2002-05-29
AU1564600A (en) 2000-06-19
CZ20011909A3 (cs) 2001-09-12
NO20012684D0 (no) 2001-05-31
WO2000032803A2 (fr) 2000-06-08
CA2353576A1 (fr) 2000-06-08
CN1348498A (zh) 2002-05-08
NO20012684L (no) 2001-07-30

Similar Documents

Publication Publication Date Title
FI962799A0 (fi) Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
BR9806747A (pt) Sistema terapêutico transdérmico.
FI820467L (fi) Farmaceutiska kompositioner som frigoers kontinuerligt
MX9700270A (es) Composicion que contiene acidos nucleicos, preparacion y utilizacion.
BRPI0111220B1 (pt) conjugados de fármacos com etilenodicisteína (ec)
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
ES2192586T3 (es) Formulaciones y procedimientos para reducir la irritacion de la piel.
BR9811019A (pt) Composição para condicionamento de cabelo
BR9811478A (pt) Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral
BR0213111A (pt) Produto cosmético
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
ATE284996T1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
BR9912275A (pt) Formulação de bioimplante
BR9508888A (pt) Agente de contraste utilização de um agente de contraste processos para gerar imagens melhoradas de um corpo humano ou de animal não humano e para preparar de um agente de contraste e um polímero polímeros biodegradáveis e implante cirúrgico
NO20002487D0 (no) Preparat med azelainsyre
BR9914644A (pt) Composições tamponadas para diálise
BR9916620A (pt) Derivados de fenetil-5-bromopiridiltiouréia (pbt) e diidroalcoxibenziloxopirimidina (dabo) exibindo atividade espermicida
BR9915897A (pt) Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos.
BR0108405A (pt) Agente de ativação de célula
BR9907269A (pt) Agente de transferência de ácidos nucleicos, composição, utilização de um agente de transferência, e, processos de transferência de ácidos nucleicos nas células, de preparação de uma composição e de tratamento de doenças.
BR9809953A (pt) Agente transfectante, composição, utlização do agente transfectante e processos de preparação de um agente transfectante e de transferência de ácidos nucleicos nas células
BR0009194A (pt) Composição do resorcinol
BR0212744A (pt) Formulações de cisplatina de toxicidade reduzida e métodos para uso das mesmas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.